Hepatotoxic effects of methotrexate
β Scribed by Evan M. Hersh; Vernon G. Wong; Edward S. Henderson; Emil J Freireich
- Publisher
- John Wiley and Sons
- Year
- 1966
- Tongue
- English
- Weight
- 819 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Hepatotoxicity of methotrexate (MTX) therapy was studied in 22 patients
π SIMILAR VOLUMES
We undertook a dose-response study in Wistar rats to develop an animal model for methotrexate hepatotoxicity. Rats were given oral methotrexate in 300, 200, 150 and 100 pg/kg/day doses for variable lengths of time. The 300 pg/kg/day dose produced systemic toxicity; the animals needed to be killed ea
The haematological and hepatotoxic effects were studied after oral administration of Isoprocarb at 75, 112.5 and 150 mg kg-' daily for 21 days in male and female chicken Gallus gallus domesficus (White Leghorns). The toxic effects as observed 10 or 21 days after medication include a statistically si
Ten histological criteria were evaluated semiquantitatively in the liver biopsies of 60 patients with rheumatoid arthritis (RA) before initiation of methotrexate (MTX) and were compared with 40 biopsies taken during MTX treatment (mean cumulative dose 1,322 mg). Meaenchymal changes (Kupffer cell pro
Hepatotoxic effects of ti-hexane and n-heptane administered i.p. ( I ml/kg body wt) were studied in albino rats after 1, 2, 7 and 45 days of treatment. Hepatic protein content decreased with n-heptane and total sulphydryl content showed a significant decrease in the rats exposed to either solvent. A